Over the past 30 years, pharmacological therapy for PHT is consisting mainly of the continued oral administration of non‐selective beta‐blockers (propranolol, nadolol, carvedilol) for the prevention of first or recurrent variceal bleeding, and on the short‐term intravenous infusion of terlipressin, somatostatin, or somatostatin analogues for acute variceal bleeding.6 The gene discussed is SST; the disease is pulmonary hypertension, primary, 1.